The potential global market size and public health value of hypothetical HIV-1 preventive vaccines with different levels of efficacy

被引：0
|
作者：
Marzetta, C. A. [1 ]
Wrobel, S. J. [1 ]
Singh, K. K. [2 ]
Russell, N. D. [2 ]
Esparza, J. [2 ]
机构：
[1] Applied Strategies Consulting, San Mateo, CA USA
[2] Bill & Melinda Gates Fdn, Seattle, WA USA
来源：
RETROVIROLOGY | 2009年 / 6卷
关键词：
Market Size; Product Profile; Campaign Vaccination; Potential Demand; Vaccination Period;
D O I：
10.1186/1742-4690-6-S3-P210
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：2
相关论文
共 13 条
  • [1] P15-09. The potential global market size and public health value of hypothetical HIV-1 preventive vaccines with different levels of efficacy
    CA Marzetta
    SJ Wrobel
    KK Singh
    ND Russell
    J Esparza
    Retrovirology, 6
  • [2] The potential global market size and public health value of an HIV-1 vaccine in a complex global market
    Marzetta, Carol A.
    Lee, Stephen S.
    Wrobel, Sandra J.
    Singh, Kanwarjit J.
    Russell, Nina
    Esparza, Jose
    VACCINE, 2010, 28 (30) : 4786 - 4797
  • [3] Potential public health impact of imperfect HIV type 1 Vaccines
    Anderson, R
    Hanson, M
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 : S85 - S96
  • [4] POTENTIAL IMPACT OF LOW EFFICACY HIV-1 VACCINES IN POPULATIONS WITH HIGH-RATES OF INFECTION
    ANDERSON, RM
    SWINTON, J
    GARNETT, GP
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1995, 261 (1361) : 147 - 151
  • [5] Theoretical assessment of public health impact of imperfect prophylactic HIV-1 vaccines with therapeutic benefits
    Elbasha, Elamin H.
    Gumel, Abba B.
    BULLETIN OF MATHEMATICAL BIOLOGY, 2006, 68 (03) : 577 - 614
  • [6] Theoretical Assessment of Public Health Impact of Imperfect Prophylactic HIV-1 Vaccines with Therapeutic Benefits
    Elamin H. Elbasha
    Abba B. Gumel
    Bulletin of Mathematical Biology, 2006, 68
  • [7] Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
    Will Fischer
    Simon Perkins
    James Theiler
    Tanmoy Bhattacharya
    Karina Yusim
    Robert Funkhouser
    Carla Kuiken
    Barton Haynes
    Norman L Letvin
    Bruce D Walker
    Beatrice H Hahn
    Bette T Korber
    Nature Medicine, 2007, 13 : 100 - 106
  • [8] Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
    Fischer, Will
    Perkins, Simon
    Theiler, James
    Bhattacharya, Tanmoy
    Yusim, Karina
    Funkhouser, Robert
    Kuiken, Carla
    Haynes, Barton
    Letvin, Norman L.
    Walker, Bruce D.
    Hahn, Beatrice H.
    Korber, Bette T.
    NATURE MEDICINE, 2007, 13 (01) : 100 - 106
  • [9] SUITABILITY OF TRINIDAD/TOBAGO AS A POTENTIAL SITE FOR PHASE-III EFFICACY STUDIES OF HIV-1 VACCINES
    PAUL, R
    CLEGHORN, F
    JACK, N
    EDWARDS, J
    MAHABIR, B
    MURPHY, J
    BLATTNER, W
    BARTHOLOMEW, C
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S9 - S9
  • [10] Consistent efficacy of B/F/TAF in treatment-naïve HIV patients across different baseline HIV-1 RNA levels at week 48
    He, Kun
    Zhou, Yihong
    Yang, Honghong
    Lu, Yanqiu
    Tan, Qiuxiang
    Qi, Weiwei
    Liu, Min
    CHINESE MEDICAL JOURNAL, 2023, 136 (22) : 2747 - 2749
12